Operating income decreased 98.3%
Operating income changed -98.3% from the comparable as-filed period.
$2.2M→$38,4543 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TAYD financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 2211 bp lower
Operating margin changed -2211 basis points from the comparable as-filed period.
22.64%→0.53%3 prior comparisons
Cash & equivalents increased 67.2%
Cash & equivalents changed +67.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$2.2M→$3.6M3 prior comparisons
Gross margin moved 1518 bp lower
Gross margin changed -1518 basis points from the comparable as-filed period.
44.75%→29.57%3 prior comparisons
Net income decreased 79.1%
Net income changed -79.1% from the comparable as-filed period.
$2.2M→$456,9333 prior comparisons
Operating cash flow changed across a low base
Operating cash flow changed +1510.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base. This reverses 3 consecutive comparable moves in the opposite direction.
$483,628→$7.8M3 prior comparisons
Revenue decreased 26.4%
Revenue changed -26.4% from the comparable as-filed period.
$9.9M→$7.3M3 prior comparisons
Current liabilities increased 26.3%
Current liabilities changed +26.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$6.0M→$7.6M3 prior comparisons
Inventory / revenue moved 4241 bp higher
Inventory / revenue changed +4241 basis points from the comparable as-filed period.
85.75%→128.16%3 prior comparisons
Gross profit decreased 51.4%
Gross profit changed -51.4% from the comparable as-filed period.
$4.4M→$2.2M3 prior comparisons
Free-cash-flow proxy changed across a low base
Free-cash-flow proxy changed +2426.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$298,641→$7.5M3 prior comparisons
Research & development increased 88.2%
Research & development changed +88.2% from the comparable as-filed period.
$80,817→$152,0743 prior comparisons
Current assets increased 18.8%
Current assets changed +18.8% from the comparable as-filed period.
$55.6M→$66.1M3 prior comparisons
Working capital increased 17.9%
Working capital changed +17.9% from the comparable as-filed period.
$49.6M→$58.4M3 prior comparisons
Total assets increased 15.2%
Total assets changed +15.2% from the comparable as-filed period.
$70.3M→$81.0M3 prior comparisons
Operating cash-flow margin moved 10179 bp higher
Operating cash-flow margin changed +10179 basis points from the comparable as-filed period.
4.88%→106.66%3 prior comparisons
Free-cash-flow margin moved 10033 bp higher
Free-cash-flow margin changed +10033 basis points from the comparable as-filed period.
3.01%→103.34%3 prior comparisons
Stockholders' equity increased 14.2%
Stockholders' equity changed +14.2% from the comparable as-filed period.
$64.3M→$73.4M3 prior comparisons
Capital expenditure increased 30.9%
Capital expenditure changed +30.9% from the comparable as-filed period.
$184,987→$242,2383 prior comparisons
Capex / revenue moved 145 bp higher
Capex / revenue changed +145 basis points from the comparable as-filed period.
1.87%→3.32%3 prior comparisons
Working capital / assets moved 161 bp higher
Working capital / assets changed +161 basis points from the comparable as-filed period.
70.55%→72.16%3 prior comparisons
Inventory increased 10.0%
Inventory changed +10.0% from the comparable as-filed period.
$8.5M→$9.4M3 prior comparisons
R&D / revenue moved 127 bp higher
R&D / revenue changed +127 basis points from the comparable as-filed period.
0.81%→2.08%3 prior comparisons
Current ratio decreased 6.0%
Current ratio changed -6.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
9.21→8.663 prior comparisons
Operating cash flow / net income changed across a low base
Operating cash flow / net income changed +7616.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
0.22→17.043 prior comparisons
Selling, general & administrative decreased 6.8%
Selling, general & administrative changed -6.8% from the comparable as-filed period.
$2.1M→$2.0M3 prior comparisons
Cost of revenue decreased 6.2%
Cost of revenue changed -6.2% from the comparable as-filed period.
$5.5M→$5.1M3 prior comparisons
Free-cash-flow proxy decreased 95.7%
Free-cash-flow proxy changed -95.7% from the comparable as-filed period.
$8.8M→$381,6771 prior comparisons
Operating cash flow decreased 90.1%
Operating cash flow changed -90.1% from the comparable as-filed period.
$9.0M→$896,8921 prior comparisons
Gross margin moved 267 bp lower
Gross margin changed -267 basis points from the comparable as-filed period.
42.87%→40.20%1 prior comparisons
Current liabilities decreased 57.0%
Current liabilities changed -57.0% from the comparable as-filed period.
$12.3M→$5.3M2 prior comparisons
Working capital increased 26.7%
Working capital changed +26.7% from the comparable as-filed period.
$44.0M→$55.8M2 prior comparisons
Capex / revenue moved 284 bp higher
Capex / revenue changed +284 basis points from the comparable as-filed period.
1.77%→4.61%1 prior comparisons
Net income increased 24.8%
Net income changed +24.8% from the comparable as-filed period.
$2.0M→$2.5M1 prior comparisons
Operating margin moved 161 bp higher
Operating margin changed +161 basis points from the comparable as-filed period.
19.12%→20.73%1 prior comparisons
Inventory / revenue moved 1639 bp lower
Inventory / revenue changed -1639 basis points from the comparable as-filed period.
83.34%→66.96%1 prior comparisons
Operating income increased 14.7%
Operating income changed +14.7% from the comparable as-filed period.
$2.0M→$2.3M1 prior comparisons
Capital expenditure increased 174.9%
Capital expenditure changed +174.9% from the comparable as-filed period.
$187,427→$515,2151 prior comparisons
Current ratio increased 152.1%
Current ratio changed +152.1% from the comparable as-filed period.
4.57→11.522 prior comparisons
Research & development decreased 57.1%
Research & development changed -57.1% from the comparable as-filed period.
$146,749→$63,0151 prior comparisons
Working capital / assets moved 1116 bp higher
Working capital / assets changed +1116 basis points from the comparable as-filed period.
62.79%→73.96%2 prior comparisons
Stockholders' equity increased 21.4%
Stockholders' equity changed +21.4% from the comparable as-filed period.
$57.8M→$70.1M1 prior comparisons
Operating cash flow / net income decreased 92.0%
Operating cash flow / net income changed -92.0% from the comparable as-filed period.
4.51→0.361 prior comparisons
Free-cash-flow margin moved 8021 bp lower
Free-cash-flow margin changed -8021 basis points from the comparable as-filed period.
83.63%→3.42%1 prior comparisons
Operating cash-flow margin moved 7738 bp lower
Operating cash-flow margin changed -7738 basis points from the comparable as-filed period.
85.40%→8.03%1 prior comparisons
Revenue increased 5.8%
Revenue changed +5.8% from the comparable as-filed period.
$10.6M→$11.2M1 prior comparisons
Inventory decreased 15.0%
Inventory changed -15.0% from the comparable as-filed period.
$8.8M→$7.5M2 prior comparisons
Cash & equivalents increased 9.9%
Cash & equivalents changed +9.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.3M→$2.5M2 prior comparisons
Current assets increased 8.4%
Current assets changed +8.4% from the comparable as-filed period.
$56.4M→$61.1M2 prior comparisons
Total assets increased 7.6%
Total assets changed +7.6% from the comparable as-filed period.
$70.1M→$75.5M2 prior comparisons
Cost of revenue increased 10.7%
Cost of revenue changed +10.7% from the comparable as-filed period.
$6.0M→$6.7M1 prior comparisons
Selling, general & administrative decreased 10.6%
Selling, general & administrative changed -10.6% from the comparable as-filed period.
$2.4M→$2.1M1 prior comparisons
R&D / revenue moved 83 bp lower
R&D / revenue changed -83 basis points from the comparable as-filed period.
1.39%→0.56%1 prior comparisons
Gross profit decreased 0.8%
Gross profit changed -0.8% from the comparable as-filed period.
$4.5M→$4.5M1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.